Pyrovalerone analogs and therapeutic uses thereof

Details for Australian Patent Application No. 2004280256 (hide)

Owner Organix, Inc. President and Fellows of Harvard College

Inventors Meltzer, Peter C.; Butler, David; Madras, Bertha K.

Agent Spruson & Ferguson

Pub. Number AU-A-2004280256

PCT Pub. Number WO2005/034878

Priority 60/509,882 08.10.03 US

Filing date 8 October 2004

Wipo publication date 21 April 2005

International Classifications

C07D 207/06 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/034878 Priority application(s): WO2005/034878

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004280257-Treatment of diseases involving ErbB2 kinase overexpression

2004280253-Dual line conveyor system and method